Vaccine acellulaire

European patent · EP0747058 · Deleted

Register entry

Publication number
EP0747058
Application number
EP96112324
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Apr 26, 1990
Published
Dec 11, 1996
Granted
Sep 22, 2004
Deleted
Sep 22, 2004
Reason
Revoked in opposition
IPC classes
A61K 39/10 (2006.01)
Priority
GB 8910570 08.05.1989
Divided from
EP90907222
Filing language
English
Source
Swissreg

Supplementary protection certificates

A certificate extends the patent’s protection for a medicine or a plant protection product authorised in Switzerland.

Filamentöses Hämagglutinin (FHA) + Pertactin

C00747058/07 · Medicine · Granted · Protection from Apr 26, 2010 to Sep 4, 2010

Authorisation 580 (BAG, Sep 5, 1995)

Deleted, Maximum term reached
Diphtheria toxoid + Tetanus toxoid + Pertussis toxoid + filamentöses Hämagglutinin + Pertactin + inaktiviertes Poliovirus Typ 1 + inaktiviertes Poliovirus Typ 2 + inaktiviertes Poliovirus Typ 3 + kapsuläres Polysaccharid des Hämophilus influenzae Typ b (Hib)

C00747058/06 · Medicine · Granted · Protection from Apr 26, 2010 to Sep 28, 2013

Authorisation 619 (BAG, Sep 29, 1998)

Deleted, Maximum term reached
Diphtheria toxoid + Tetanus toxoid + Pertussis toxoid + filamentöses Hämagglutinin + Pertactin + kapsuläres Polysaccharid des Hämophilus influenzae Typ b (Hib)

C00747058/05 · Medicine · Application · Protection from Apr 26, 2010 to Feb 25, 2012

Authorisation 595 (BAG, Feb 26, 1997)

Deleted, Refused
Diphtheria toxoid + Tetanus toxoid + Pertussis toxoid + filamentöses Hämagglutinin + Pertactin + inaktiviertes Poliovirus Typ 1 + inaktiviertes Poliovirus Typ 2 + inaktiviertes Poliovirus Typ 3

C00747058/04 · Medicine · Granted · Protection from Apr 26, 2010 to Aug 19, 2014

Authorisation 638 (BAG, Aug 20, 1999)

Deleted, Maximum term reached
Diphtheria toxoid + Tetanus toxoid + Pertussis toxoid + filamentöses Hämagglutinin + Pertactin + rekombinantes Hepatitis B-Virus-Oberflächenantigen (S-Protein) + inaktiviertes Poliovirus Typ 1 + inaktiviertes Poliovirus Typ 2 + inaktiviertes Poliovirus Typ 3 + kapsuläres Polysaccharid des Hämophilus influenzae Typ b (Hib)

C00747058/03 · Medicine · Granted · Protection from Apr 26, 2010 to Apr 25, 2015

Authorisation 640 (BAG, Oct 2, 2000)

Deleted, Maximum term reached
Diphtheria toxoid + Tetanus toxoid + Pertussis toxoid + filamentöses Hämagglutinin + Pertactin + rekombinantes Hepatitis B-Virus-Oberflächenantigen (S Protein) + inaktiviertes Poliovirus Typ 1 + inaktivierties Poliovirus Typ 2 + inaktiviertes Poliovirus Typ 3

C00747058/02 · Medicine · Granted · Protection from Apr 26, 2010 to Apr 25, 2015

Authorisation 639 (BAG, Oct 2, 2000)

Deleted, Authorisation revoked
Diphtheria toxoid + Tetanus toxoid + Pertussis toxoid + filamentöses Hämagglutinin + Pertactin + rekombinantes Hepatitis B-Virus-Oberflächenantigen (S Protein)

C00747058/01 · Medicine · Granted · Protection from Apr 26, 2010 to Oct 20, 2012

Authorisation 604 (BAG, Oct 21, 1997)

Deleted, Maximum term reached

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 25, 2024

    Change

    Published in Swissreg on 25.06.2024

  2. Jun 25, 2024

    Change

    Published in Swissreg on 25.06.2024

  3. May 3, 2010

    Maximum term reached

    Published in Swissreg on 03.05.2010

  4. Dec 31, 2004

    Agent entered

    Representative
    Patentanwälte, Schaad, Balass, Menzl & Partner AG, Dufourstrasse 101, 8034 Zürich

    Published in +pat+ No 24 in 2004

  5. Sep 30, 2004

    Granted

    Published in +pat+ No 18 in 2004

Parties

Inventor

Novotny, Pavel

Bromley, Kent, BR2 0BT, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.